HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest Articles

Latest from PR Newswire

Click here to access further cosmetics and dietary supplement news.

Health Explore this Topic

Set Alert for Health

Latest From Health

Over the Counter 29 June 2022: OTC Birth Control In The Wake Of The US Supreme Court Decision With Victoria Nichols

In this episode, HBW Insight speaks to Victoria Nichols, project director of Free the Pill, a campaign supporting increased OTC oral contraceptive access in the US. In the wake of the Supreme Court’s decision to overturn Roe v. Wade on 24 June, Nichols discusses the importance of advocating for OTC birth control, the limited availability of OTC oral contraceptives in the US, and the current legislation being introduced that would help ensure OTC birth control is covered by insurance. 

United States OTC Drugs

Proposed Rule Making More OTC Switches Likely In US Makes More Tools Necessary For Sponsors

OTC drug development and marketing consultants spoke with HBW Insight about FDA’s “Nonprescription Drug Product with an Additional Condition for Nonprescription Use” proposed rule. In first of two articles, they discuss proposed rule’s likely impacts on industry and remaining concerns around incorporating extra-label information in drug labeling.

FDA Prescription To OTC Switch

Expanding US OTC Switches Turns On Flexibility In FDA Drug Approval Process And For Consumers

“Nonprescription Drug Product with an Additional Condition” for OTC use proposed rule would add to drug firms’ workloads for some OTC switches. Along with NDAs, sponsors would need to show a DFl isn’t sufficient to ensure a consumer can appropriately self-select and use a drug OTC and how an “additional condition” system would work.

FDA Prescription To OTC Switch

After 10 Years, US FDA ‘Additional Conditions’ Proposed Rule Offers ‘Novel Switch’ Pathway

Publication of "ACNU" proposed rule wasn’t reached in straight line and featured coining another term with more of a regulatory sound, “NSURE,” and detours on explaining where the agency wouldn’t steer OTC drug manufacturing and marketing.

FDA Prescription To OTC Switch

People On The Move: Appointments At CRN UK, EMA, Boots

A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.

Executive Changes Leadership

US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward

System likely will evolve as post-pandemic world unfolds, but adds to list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.

FDA Regulation
See All

Beauty Explore this Topic

Set Alert for Beauty

Latest From Beauty

Dinosaur Among The Unicorns: L'Oreal Talks Beauty Tech Innovation At VivaTech 2022

L’Oreal Group’s CEO referred VivaTech 2022 attendees to Yves Saint Laurent Beauty Scent-Sation, an electroencephalography-based headset that reads consumers’ emotional responses to different scent families, as an example of the firm’s beauty tech innovation that is personalizing the consumer experience, matching consumers with products, and distinguishing L’Oreal as a … err … “T-unicorn.”

Cosmetics Innovation

CIR’s 161st Expert Panel Meeting: Much Ado About Airbrush Cosmetics; Prostaglandins Make 2023 Priorities

Exactly what is in airbrush-delivered cosmetics, and how they are used by consumers, are not well understood by Cosmetic Ingredient Review, its expert panel, or the US FDA. At their June meeting, CIR’s independent experts debated who should be responsible for assessing airbrush cosmetics and how safety unknowns should be communicated.

Cosmetic Ingredients Safety

US House Appropriators Seek Data On Fragrance Allergens In Cosmetics, ‘Balance’ In Sunscreen Regs

The House Appropriations Committee asks the US Food and Drug Administration to provide a report to Congress in two years on the resources it would need to develop a database for fragrance allergens used in cosmetics. The committee’s report accompanying FY2023 FDA funding legislation also touches on OTC sunscreen regulation, PFAS in cosmetics, skin-lightening ingredients, and more.

United States Legislation

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

Europe Regulation

Cosmetic And Personal Care Weekly Trademarks Review: 21 June

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Advertising, Marketing & Sales

Advertisers Using Browsing Data To Target Ads Warned To Be Sure Consumers Have Control

BBB National Programs' Digital Advertising Accountability Program publishes compliance warning reminding businesses that consumers must have control over interest-based advertising, driven by data websites collect. For certain categories of sensitive information, websites should only use the information when consumers opt-in.

Compliance Advertising, Marketing & Sales
See All

Wellness Explore this Topic

Set Alert for Wellness

Latest From Wellness

Nestlé Spies APAC Expansion Potential With Deal for New Zealand's Better Health

Nestlé Health Science continues to expand its dietary supplements offering in 2022 penning a deal for New Zealand's The Better Health Company and its GO Healthy brand. The company says the deal will strengthen its presence not just in New Zealand but across the wider APAC region in markets such as Australia and China.

Dietary Supplements Asia Pacific

People On The Move: Appointments At CRN UK, EMA, Boots

A round-up of the latest European executive appointments: CRN UK hires scientific advisor; EMA management board names vice chair; Boots UK appoints chief digital officer.

Executive Changes Leadership

US FDA Likely To Embrace In-Person, Remote Combo For Facility Inspections Going Forward

System likely will evolve as post-pandemic world unfolds, but adds to list of agency programs expecting to continue using virtual platforms once in-person activities are no longer restricted by COVID-19.

FDA Regulation

Health And Wellness Weekly Trademarks Review: 21 June

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs

USPSTF Doesn’t See Forest Of VMS Benefits For Trees Of Reducing Cancer, Heart Disease Risks

US Preventative Services Task Force concludes evidence doesn't support  recommending VMS use to prevent cancer or cardiovascular disease. Trade groups and a natural medicine expert say task force's focus is narrow and its recommendation misleading. 

Dietary Supplements Research & Development

France's Havea Set For New Private-Equity Owners

French natural consumer health specialist Havea looks set to be snapped up by private-equity firm BC Partners, which has set out a plan to step up the company's M&A and digitization activities. 

Deals France
See All

Market Intelligence Explore this Topic

Set Alert for Market Intelligence

Latest From Market Intelligence

Over the Counter 29 June 2022: OTC Birth Control In The Wake Of The US Supreme Court Decision With Victoria Nichols

In this episode, HBW Insight speaks to Victoria Nichols, project director of Free the Pill, a campaign supporting increased OTC oral contraceptive access in the US. In the wake of the Supreme Court’s decision to overturn Roe v. Wade on 24 June, Nichols discusses the importance of advocating for OTC birth control, the limited availability of OTC oral contraceptives in the US, and the current legislation being introduced that would help ensure OTC birth control is covered by insurance. 

United States OTC Drugs

Health And Wellness Weekly Trademarks Review: 21 June

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs

Cosmetic And Personal Care Weekly Trademarks Review: 21 June

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Advertising, Marketing & Sales
See All
UsernamePublicRestriction

Register